Annual CFF
$257.00 K
-$113.00 K-30.54%
31 December 2023
Summary:
Atea Pharmaceuticals annual cash flow from financing activities is currently $257.00 thousand, with the most recent change of -$113.00 thousand (-30.54%) on 31 December 2023. During the last 3 years, it has fallen by -$1.21 million (-82.46%). AVIR annual CFF is now -99.95% below its all-time high of $531.75 million, reached on 31 December 2020.AVIR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$117.00 K
+$117.00 K+100.00%
30 September 2024
Summary:
Atea Pharmaceuticals quarterly cash flow from financing activities is currently $117.00 thousand, with the most recent change of +$117.00 thousand (+100.00%) on 30 September 2024. Over the past year, it has increased by +$117.00 thousand (+100.00%). AVIR quarterly CFF is now -99.97% below its all-time high of $426.22 million, reached on 31 December 2020.AVIR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$267.00 K
+$25.00 K+10.33%
30 September 2024
Summary:
Atea Pharmaceuticals TTM cash flow from financing activities is currently $267.00 thousand, with the most recent change of +$25.00 thousand (+10.33%) on 30 September 2024. Over the past year, it has increased by +$10.00 thousand (+3.89%). AVIR TTM CFF is now -99.95% below its all-time high of $532.23 million, reached on 31 March 2021.AVIR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVIR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +3.9% |
| 3 y3 years | -82.5% | -17.6% | -81.8% |
| 5 y5 years | +100.0% | - | - |
AVIR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.5% | at low | -47.5% | -81.8% | +10.3% | |
| 5 y | 5 years | -100.0% | -100.0% | +112.8% | -100.0% | +4550.0% | |
| alltime | all time | -100.0% | -100.0% | +112.8% | -100.0% | +4550.0% |
Atea Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $117.00 K(>+9900.0%) | $267.00 K(+10.3%) |
| June 2024 | - | $0.00(-100.0%) | $242.00 K(0.0%) |
| Mar 2024 | - | $150.00 K(>+9900.0%) | $242.00 K(-5.8%) |
| Dec 2023 | $257.00 K(-30.5%) | $0.00(-100.0%) | $257.00 K(0.0%) |
| Sept 2023 | - | $92.00 K(>+9900.0%) | $257.00 K(-17.6%) |
| June 2023 | - | $0.00(-100.0%) | $312.00 K(0.0%) |
| Mar 2023 | - | $165.00 K(>+9900.0%) | $312.00 K(-15.7%) |
| Dec 2022 | $370.00 K | $0.00(-100.0%) | $370.00 K(-27.7%) |
| Sept 2022 | - | $147.00 K(>+9900.0%) | $512.00 K(-55.9%) |
| June 2022 | - | $0.00(-100.0%) | $1.16 M(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $223.00 K(+57.0%) | $1.22 M(-16.9%) |
| Dec 2021 | $1.47 M(-99.7%) | $142.00 K(-82.1%) | $1.47 M(-99.7%) |
| Sept 2021 | - | $795.00 K(+1294.7%) | $427.54 M(+0.4%) |
| June 2021 | - | $57.00 K(-87.9%) | $425.83 M(-20.0%) |
| Mar 2021 | - | $471.00 K(-99.9%) | $532.23 M(+0.1%) |
| Dec 2020 | $531.75 M(>+9900.0%) | $426.22 M(<-9900.0%) | $531.75 M(+403.9%) |
| Sept 2020 | - | -$913.00 K(-100.9%) | $105.53 M(-0.9%) |
| June 2020 | - | $106.45 M(<-9900.0%) | $106.44 M(<-9900.0%) |
| Mar 2020 | - | -$6000.00 | -$6000.00 |
| Dec 2019 | $0.00(-100.0%) | - | - |
| Dec 2018 | $27.48 M | - | - |
FAQ
- What is Atea Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly CFF year-on-year change?
- What is Atea Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals TTM CFF year-on-year change?
What is Atea Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AVIR is $257.00 K
What is the all time high annual CFF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual cash flow from financing activities is $531.75 M
What is Atea Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AVIR is $117.00 K
What is the all time high quarterly CFF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly cash flow from financing activities is $426.22 M
What is Atea Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AVIR quarterly cash flow from financing activities has changed by +$117.00 K (+100.00%)
What is Atea Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AVIR is $267.00 K
What is the all time high TTM CFF for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high TTM cash flow from financing activities is $532.23 M
What is Atea Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AVIR TTM cash flow from financing activities has changed by +$10.00 K (+3.89%)